Spontaneous regression of presumed ocular surface squamous neoplasia: A report of 8 cases.


Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
Sep 2022
Historique:
pubmed: 9 11 2021
medline: 13 8 2022
entrez: 8 11 2021
Statut: ppublish

Résumé

To report the phenomenon of spontaneous regression in presumed ocular surface squamous neoplasia (OSSN). Retrospective chart review of clinically diagnosed cases of OSSN during 2016 to 2019. Of the 449 OSSN lesions, spontaneous regression was seen in 8 lesions (2%). The mean age at diagnosis of OSSN was 37 years (median, 36 years; range, 21 to 59 years). All were males with unilateral, treatment-naïve tumors. Mean duration of symptoms was 3 months (median, 2 months; range, 1 to 12 months). All tumors arose within the interpalpebral region, located in the nasal quadrant in 88% (n = 7) and in temporal quadrant in 12% (n = 1). The mean tumor diameter was 4 mm (median, 4 mm; range, 3 to 5 mm). Lesions showed nodular (n = 4; 50%) or placoid (n = 4; 50%) morphology. The other features included keratin production and intrinsic vascularity (n = 8; 100%), feeder vessels (n = 4; 50%), and intratumoral pigmentation (n = 4; 50%). The diagnosis of OSSN was confirmed by classic anterior segment optical coherence tomography (AS-OCT) features. Tumors regressed after a mean period of 5 months (median, 4 months; range, <1 to 17 months) from presumed onset and a mean period of 2 months (median, 1 month; range, <1 to 6 months) from presentation to the clinic. No recurrences were noted at a mean follow up of 37 months (median, 35 months; range, 17 to 52 months) after spontaneous regression of tumors. OSSN can spontaneously regress in 2% of cases. Immune-mediated reversal of dysplastic changes may explain this phenomenon. In this study, spontaneous regression of presumed ocular surface squamous neoplasia was noted in 2% patients. Tumor regression resulted in restoration of normal epithelial architecture and no recurrences were observed during the follow-up period.

Identifiants

pubmed: 34747253
doi: 10.1177/11206721211057340
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3029-3034

Auteurs

Vijitha S Vempuluru (VS)

Operation Eyesight Universal Institute for Eye Cancer, 28592LV Prasad Eye Institute, Hyderabad, India.

Neha Ghose (N)

Operation Eyesight Universal Institute for Eye Cancer, 28592LV Prasad Eye Institute, Hyderabad, India.

Nidhi Mahendra Vithalani (NM)

Operation Eyesight Universal Institute for Eye Cancer, 28592LV Prasad Eye Institute, Hyderabad, India.

Shahenaz Sultana (S)

Brien Holden Institute of Optometry and Vision Sciences, 28592LV Prasad Eye Institute, Hyderabad, India.

Swathi Kaliki (S)

Operation Eyesight Universal Institute for Eye Cancer, 28592LV Prasad Eye Institute, Hyderabad, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH